Zusammenfassung
Die kalzifizierte Aortenklappenstenose ist der häufigste Herzklappenfehler. Betroffen sind ältere Menschen, die häufig zusätzlich Komorbiditäten wie linksventrikuläre Dysfunktion, eingeschränkte Nierenfunktion und pulmonale Hypertonie aufweisen. Das operative Risiko ist erhöht. Mit der perkutanen Valvuloplastie der Aortenklappe können eine Symptomreduktion und Zunahme der Leistungsfähigkeit und damit eine bessere Lebensqualität erreicht werden. Neuere Ergebnisse zeigen sogar eine verbesserte Überlebensrate. Neue Techniken haben zu einem „Revival“ dieser vor gut 20 Jahren implementierten Methode geführt. Im akuten Notfall mit kardialer Dekompensation ist die Letalität weiterhin hoch. Eine Stabilisierung zur Vermeidung von ventrikulären Arrhythmien oder elektromechanischer Entkoppelung kann durch die Anwendung von Amiodaron erreicht werden. Eine intensivmedizinische Stabilisierung des Patienten vor Durchführung der Valvuloplastie ist ratsam. Bei Restenosen von Bioprothesen lässt sich mit der Valvuloplastie nur kurzfristig eine Verbesserung der Hämodynamik erzielen. Ein chirurgischer Aortenklappenersatz oder eine perkutane Prothesenimplantation („valve-in-valve“) muss rasch durchgeführt werden.
Abstract
Calcified aortic stenosis is the dominating valve disease. Patients affected are most commonly elderly people, who often show associated comorbidities like reduced left ventricular function, impaired renal function, and pulmonary hypertension. The risk of open heart surgery is elevated. Balloon aortic valvuloplasty enables a reduction of symptoms, an increase in physical performance, and, therefore, an improved quality of life. Recent data also demonstrated an improved survival of patients after valvuloplasty. New techniques and improved equipment induced a “revival” of balloon aortic valvuloplasty, which has been introduced more than 20 years ago. In acute emergencies, however, mortality is high. Hemodynamic stabilization in the intensive care unit prior to valvuloplasty is recommended. If restenosis in aortic bioprosthesis has occurred, hemodynamic improvement is very limited. Surgical valve replacement or percutaneous transcatheter valve implantation as valve-in-valve must be considered in the short term.
Literatur
Agarwal A, Kini AS, Attani S, et al. Results of repeat balloon valvuloplasty for treatment of aortic stenosis in patients aged 59 to 104 years. Am J Cardiol 2005;95:43–7.
Agatiello C, Eltchaninoff H, Tron C, et al. Balloon aortic valvuloplasty in the adult. Immediate results and in-hospital complications in the latest series of 141 consecutive patients at the University Hospital of Rouen (2002–2005). Arch Mal Coeur Vaiss 2006;99:195–200.
Block PC, Palacios PG. Comparison of hemodynamic results of anterograde versus retrograde percutaneous ballon aortic valvuloplasty. Am J Cardiol 1987;60:659–62.
Bonow RO, Carabello B, Kanu C, et al. ACC/AHA 2008 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients with Valvular Heart Disease): developed in collaboration with the Society of Anesthesiologists: endorsed by the Society of Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 2006;114:e84–231.
Brady ST, Davis CA, Kussmaul WG, et al. Percutaneous aortic balloon valvuloplasty in octogenarians: morbidity and mortality. Ann Intern Med 1989;110:761–6.
Bussmann WD, Reifart N, Sievert H, et al. Transfemorale Valvuloplastik bei verkalkter Aortenklappenstenose. Dtsch Med Wochenschr 1987;112:723–5.
Cosmi JE, Kort S, Tunick PA, et al. The risk of the development of aortic stenosis in patients with “benign” aortic valve thickening. Arch Intern Med 2002;162:2345–7.
Cribier A, Savin T, Berland T, et al. Percutaneous transluminal valvuloplasty in acquired aortic stenosis in elderly patients: an alternative to valve replacement? Lancet 1986:1:63–7.
Cribier A, Savin T, Berland J, et al. Percutaneous transluminal balloon valvuloplasty of adult aortic stenosis: report of 92 cases. J Am Coll Cardiol 1987;9:381–6.
Drobinski G, Lechat P, Metzger JP, et al. Results of percutaneous catheter valvuloplasty for calcified aortic stenosis in the elderly. Eur Heart J 1987;8:322–8.
Erdmann E, Höfling B. Perkutane transfemorale Valvuloplastie der verkalkten und nicht verkalkten Aortenklappe im Erwachsenenalter. Dtsch Med Wochenschr 1986;111:504–6.
Feldmann T. Percutaneous suture closure for management of large French size arterial and venous puncture. J Interv Cardiol 2000;13:237–42.
Freeman RV, Otto CM. Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies. Circulation 2005;111:3316–26.
Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on valvular heart disease. Eur Heart J 2003;24:1231–43.
Kahlert P, Eggebrecht H, Erbel R, et al. A modified “preclosure” technique after percutaneous aortic valve replacement. Cathet Cardiovasc Interv 2008;72:877–84.
Khandapour S, Kahlert P, Erbel R, et al. Verbesserte Patientensicherheit bei der Valvuloplastie der kalzifizierten Aortenklappenstenose durch Ermittlung der optimalen Stimulationsfrequenz. Clin Res Cardiol 2008;97:Suppl 1:P1534.
Klein A, Lee K, Gera A, et al. Long-term mortality, cause of death, and temporal trends in complications after percutaneous aortic balloon valvuloplasty for calcified aortic stenosis. J Interv Cardiol 2006;19:269–75.
Lieberman EB, Bashore TM, Hermiller JB, et al. Balloon aortic valvuloplasty in adults: failure of procedure to improve long-term survival. J Am Coll Cardiol 1995;26:1522–8.
Litvack F, Jakubowski AT, Buchbinder NA, et al. Lack of sustained clinical improvement in an elderly population after percutaneous aortic valvuloplasty. Am J Cardiol 1988;62:270–5.
McKay RG, Safian RD, Lock JE, et al. Balloon aortic valvuloplasty of calcified aortic stenosis in elderly patients: postmortem, intraoperative and percutaneous valvuloplasty studies. Circulation 1986;74:119–25.
Melby SJ, Zierer A, Kaiser SP, et al. Aortic valve replacement in octogenarians. Risk factors for early and late mortality. Ann Thorac Surg 2007;83:1651–6.
Michaels AD, Porst TA. Use of a percutaneous arterial suture device (Perclose) in patients undergoing percutaneous aortic valvuloplasty. Cathet Cardiovasc Interv 2001;53:445–7.
Nashef SAM, Roques F, Michel P, et al. European system for cardiac risk evaluation (EuroSCORE). Eur Heart J 1999;16:9–13.
Newman MF, Kirchner JL, Phillips-Bute B, et al., Neurological Outcome Research Group and the Cardiothoracic Anesthesiology Research Endeavours Investigators. Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery. N Engl J Med 2001;344:395–402.
O’Keefe JHJr, Vlietstra RE, Bailey KR, et al. Natural history of candidates for balloon aortic valvuloplasty. Mayo Clin Proc 1987;62:986–91.
Otto CM, Mickel MC, Kennedy W, et al. Three-year outcome after balloon aortic valvuloplasty. Insights into prognosis of valvular aortic stenosis. Circulation 1994;89:642–50.
Pop T, Erbel R, Henrichs KJ, et al. Perkutane Angioplastie der stenosierten Aortenklappe: Ergebnisse, hämodynamische Auswirkungen, Komplikationen. Z Kardiol 1988;77:337–45.
Roques F, Nashef SA, Michael P, et al. Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients. Eur J Cardiothorac Surg 1999;15:815–22, discussion 822-3.
Ross IJJr, Braunwald E. Aortic stenosis. Circulation 1968;37:Suppl V:V61–7.
Sack S, Henrichs KJ, Erbel R, et al. Echocardiographic and angiographic evaluation of left ventricular function during percutaneous transluminal aortic valvuloplasty. Cathet Cardiovasc Diagn 1992;26:82–91.
Sack S, Kahlert P, Khandanpour S, et al. Aortenklappenstenose: von der Valvuloplastie zum perkutanen Klappenersatz. Herz 2006;31:688–93.
Sack S, Kahlert P, Khandanpour S, et al. Revival of an old method with new techniques: balloon aortic valvuloplasty of the calcified aortic stenosis in the elderly. Clin Res Cardiol 2008; 97:288–97.
Sack S, Naber C, Kahlert P, et al. Revival of an old method with new technology: valvuloplasty of the calcified stenosis. Eur Heart J 2006;24:712.
Sanchez A, David F, Velazquez E, et al. Balloon stabilization by means of cardiac stimulation during aortic valvuloplasty. Arch Cardiol Mex 2005;75:455–9.
Scherer HE, Hörmann E, Engel HJ. Ballondilatation verkalkter Aortenstenosen. Dtsch Med Wochenschr 1987;112:1694–7.
Serruys PW, Luijten HE, Beatt KJ, et al. Percutaneous balloon aortic valvuloplasty for calcific aortic stenosis. A treatment “sine cure”? Eur Heart J 1988;9:782–94.
Shareghi S, Rasouli L, Shavelle DM, et al. Current results of balloon aortic valvuloplasty in high-risk patients. J Invasive Cardiol 2007;19:1–5.
Sievert H, Kaltenbach M, Bussmann WD, et al. Perkutane Valvuloplastik der Aortenklappe im Erwachsenenalter. Dtsch Med Wochenschr 1987;112:1067–72.
Solomon LW, Fusman B, Jolly N, et al. Percutaneous suture closure for management of large French size arterial puncture in aortic valvuloplasty. J Invasive Cardiol 2001;13:592–6.
Webb JG, Pasupati S, Achtem L, et al. Rapid pacing to facilitate transcatheter prosthetic heart valve implantation. Cathet Cardiovasc Interv 2006;68:199–204.
Zimpfer D, Czerny M, Kilo J, et al. Cognitive deficit after aortic valve replacement. Ann Thorac Surg 2002;74:407–12.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sack, S., Menne, J., Krüger, T. et al. Dekompensiertes Klappenvitium: das Revival der Ballonvalvuloplastie – perkutane Klappeninterventionen. Herz 34, 206–210 (2009). https://doi.org/10.1007/s00059-009-3233-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00059-009-3233-6